Moreover, breast cancer biopsies that are positive for estrogen (ER) and progesterone (PR) receptors biomarkers harbor a significantly higher MC infiltration than those that are negative for such receptors; however, no differences were observed when comparing HER2-positive and HER2-negative cancer samples. This evidence concerns the gene ERBB2 and breast carcinoma.